Pembrolizumab plus AVD for classical Hodgkin lymphoma, targeting the CD40/CD40-ligand axis in Waldenström Macroglobulinemia, and CXCR4-expressing CAR-cytokine induced killer cells in AML
Blood Podcast
00:00
Targeting the Immune Microenvironment in Waldenstrom Macroglobulinemia
Mai and Herrera conclude that studies of treatment de-escalation could be considered in future trials of classical Hodgkin lymphoma. Waldenstrom Macroglobulinemia is a clonal B cell malignancy characterized by the accumulation of lymphoplasmacetic cells within the bone marrow, along with a serum monoclonal immunoglobulin M or IgM protein.
Transcript
Play full episode
